1. 1144PResponses and durability of clinical benefit in non-small cell lung cancer treated with pegilodecakin in combination with anti-PD-1 inhibitors. (23rd October 2018) Authors: Garon, E B; Wong, D J; Schneider, J G; Aljumaily, R; Korn, W M; Patel, M R; Autio, K A; Papadopoulos, K P; Naing, A; Gabrail, N; Munster, P N; Goldman, J; Hung, A; Oft, M; Leveque, J; Spigel, D R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 192PDRandomized trial of lisinopril or carvedilol for the prevention of cardiotoxicity in patients with early stage HER2-positive breast cancer receiving trastuzumab. (23rd October 2018) Authors: Munster, P N; Krischer, J; Tamura, R; Bello-Matricaria, L; Fink, A; McCaskill-Stevens, W; Guglin, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Maintenance lenalidomide in primary CNS lymphoma. (2nd May 2019) Authors: Rubenstein, J L; Geng, H; Vu, K; Mannis, G; Formaker, P; Hwang, J; Munster, P N; Damato, B Journal: Annals of oncology Issue: Volume 30:Number 8(2019) Page Start: 1397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗